Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Elutia Inc. announced securing up to $26 million in funding to support the FDA clearance and full commercial launch of its antibiotic-eluting biomatrix product, NXT-41x, without issuing new equity. The company reported Q2 2026 financials showing a net loss of $7.6 million but progresses on regulatory and manufacturing milestones with strong surgeon…
AmpliTech Group, a US-based manufacturer of advanced RF and microwave components, announced Q2 2026 revenue of $8.07 million, up 50.9% sequentially, with gross profit increasing 161.2% YoY. The company invested heavily in R&D, especially in 5G and MMIC technologies, and strengthened its balance sheet with a successful Series A rights offering. It c…
Martin Marietta Materials, Inc. has increased its quarterly cash dividend from $0.83 to $0.84 per share, marking its eleventh consecutive annual dividend raise. The dividend is payable on September 30, 2026, to shareholders of record as of September 1, 2026. The company highlights its strong cash flow, durable business model, and confidence in sust…
Lianhe Sowell International Group Ltd announced its fiscal year 2026 financial results, reporting an 18% increase in total revenues to $43.27 million driven by 40% growth in electronic products. Despite top-line growth, the company posted a net loss of $5.65 million due to a 148% surge in operating expenses fueled by strategic investments in R&D an…
Celcuity Inc. reported second quarter 2026 financial results and corporate updates highlighting the FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- PIK3CA wild-type advanced breast cancer, with commercial launch expected in Q3 2026. The company also announced positive Phase 3 VIKTORIA-1 trial results in the PIK3CA mutant cohort, supporting a …
ImmuCell Corporation announced positive unaudited financial results for Q2 2026, including 11.5% revenue growth to $7.2 million and net income of $1.8 million, boosted by a $2 million legal settlement. The company is undertaking a $8 million capacity expansion to enhance manufacturing of its First Defense® calf health biologic products, aiming to t…
Parsons Corporation has been awarded a $70 million task order under the U.S. Air Force's Air Base Air Defense (ABAD) contract. Over a four-year period, Parsons will provide integration, testing, deployment, maintenance, and operational transition support for defense capabilities in the USAFE-AFAFRICA region, focusing on point defense systems agains…
Swarmer, a US-based defense technology company specializing in autonomous drone software, announced its Q2 2026 financial results. The company reported increased revenues driven by its SkyKnight licensing program and announced strategic partnerships to enhance its autonomous systems software integration. Despite revenue growth, operating expenses r…
Birchtech Corp. reported its Q2 2026 financial results, highlighting increased revenues driven by stronger air business demand and inaugural water treatment sales. The company solidified its patent protections after all challenges to its patented SEA4 mercury emissions technology were dismissed. Despite revenue growth to $3.8 million, Birchtech po…
Merlin, Inc. reported Q2 2026 results showing increased revenue and operating milestones in autonomous flight technology, including completion of a critical design review for USSOCOM's C-130J program, a first fully autonomous fixed-wing aircraft landing, and a strategic partnership with Israel Aerospace Industries. The company also progressed in ci…
Cibus, Inc. reported its second quarter 2026 financial results and provided a business update highlighting progress in commercialization of herbicide tolerance traits in rice, expansion of sustainable ingredient partnerships, and positive regulatory developments in key markets like the US and EU. The company reduced cash usage by 19% sequentially, …
Mineralys Therapeutics announced inducement equity awards granted to its newly appointed Chief Medical Officer, Dr. Terry Ferguson, including stock options and restricted stock units totaling over 237,000 shares, vesting over four years. The awards were granted under the company's 2025 Employment Inducement Incentive Award Plan in accordance with N…
Invivyd, Inc. reported second quarter 2026 financial results featuring $14.3 million in net product revenue from PEMGARDA, a 21% increase year-over-year, driven by increased patient demand. The company completed enrollment in key Phase 3 clinical trials for its novel monoclonal antibody candidate VYD2311 targeting COVID-19, with top-line data antic…
Rank One Computing Corporation (ROC), a U.S.-based Vision AI leader, reported second-quarter 2026 financial results showing sequential revenue growth of nearly 100% to $5.1 million, driven by increased government R&D contracts and commercial traction across its Vision AI product portfolio. Government R&D revenues grew by 41% year-over-year, and ROC…
WidePoint Corporation reported its second quarter 2026 financial results highlighting continued profitability with positive adjusted EBITDA for the 36th consecutive quarter and positive net income for the second consecutive quarter. The company was named the single awardee of the U.S. Department of Homeland Security (DHS) Cellular Wireless Managed …
dLocal delivered robust financial results for Q2 2026, reporting a 92% year-over-year increase in total payment volume (TPV) to nearly $18 billion and record gross profit of $127 million, up 29%. Operating profit rose 15% year-over-year to $64 million, with net income increasing 28% to $55 million. The company raised its TPV and gross profit guidan…
Mangoceuticals' merger partner, Nuclea Energy, signed a definitive agreement to acquire Moltex Energy's advanced nuclear technology assets, including patents and technologies related to advanced reactors and nuclear fuel recycling. This acquisition is expected to broaden Nuclea's nuclear technology portfolio and provide strategic entry into multipl…
Arcadia Biosciences released its Q2 and first half 2026 financial results showing a modest decrease in revenues due to inventory and shipping delays but improved operating cash usage. The company raised $4 million via private placement and is poised for growth with new Zola product launches planned for late 2026 and early 2027. Despite operational …
Rani Therapeutics reported positive Phase 1a clinical data for RT-114, an oral biologic delivery candidate demonstrating bioavailability exceeding subcutaneous dosing. The company expanded its obesity pipeline through a new collaboration with PegBio, completed a $20 million stock offering, and strengthened its leadership team. Financial results sho…
Vivani Medical reported Q2 2026 financial results, including a net loss of $6.4 million, while highlighting significant business progress. The company completed dosing in its SLIM-1 Phase 1 trial of NPM-139, a novel semaglutide implant for chronic weight management, with top-line data expected in November 2026. Vivani entered a non-exclusive agreem…
AVAX One Technology Ltd. (NASDAQ: AVX) announced its Q2 2026 financial results showing a substantial increase in total revenue to $2.8 million from $0.5 million a year earlier, primarily driven by $2.1 million in staking rewards from its Avalanche digital asset treasury and $0.7 million from bitcoin mining. Despite revenue growth, the company repor…
Xcel Brands, Inc. reported its Q2 2026 financial results featuring a net loss of $2.5 million on a GAAP basis, an improvement compared to $4.0 million loss in the prior year quarter. Adjusted EBITDA showed a 40% improvement when excluding non-recurring expenses, driven by new influencer-led product launches and reduced operating expenses. Revenue d…
Capricor Therapeutics reported Q2 2026 financial results along with updates on the regulatory review of Deramiocel, their lead cell therapy for Duchenne muscular dystrophy (DMD). The FDA advisory committee voted 9-3 against substantial evidence of effectiveness of Deramiocel for treating cardiomyopathy in DMD, impacting approval prospects. However,…
Jefferson Capital, Inc., a purchaser and manager of consumer receivables, announced its second quarter 2026 results highlighting an 18% increase in collections to $300.9 million and a 21% rise in deployments to $152.2 million. Estimated Remaining Collections grew 18% to $3.4 billion. The company reported pre-tax income of $53.3 million and net inco…
Dynagas LNG Partners LP announced a quarterly cash distribution of $0.050 per common unit for the quarter ended June 30, 2026, payable on August 28, 2026. The Partnership owns six LNG carriers operating on multi-year charters with a combined carrying capacity of approximately 914,000 cubic meters.
